Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation …
Vaccination with neem leaf glycoprotein matured carcinoembryonic antigen (CEA) pulsed
dendritic cells (DCs) enhances antigen-specific humoral and cellular immunity against CEA …
dendritic cells (DCs) enhances antigen-specific humoral and cellular immunity against CEA …
Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions
In an objective to find out an effective, nontoxic dendritic cell (DC) maturating agent for
human use, CD14+ monocytes were differentiated with GMCSF/IL-4 and matured with neem …
human use, CD14+ monocytes were differentiated with GMCSF/IL-4 and matured with neem …
Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation
In an objective to generate effective carcinoembryonic antigen (CEA) specific anti-tumor
immune response in Swiss mice, CEA was presented using macrophages with adjuvant …
immune response in Swiss mice, CEA was presented using macrophages with adjuvant …
Neem leaf glycoprotein promotes dual generation of central and effector memory CD8+ T cells against sarcoma antigen vaccine to induce protective anti-tumor …
We have previously shown that Neem Leaf Glycoprotein (NLGP) mediates sustained tumor
protection by activating host immune response. Now we report that adjuvant help from NLGP …
protection by activating host immune response. Now we report that adjuvant help from NLGP …
[HTML][HTML] Neem Leaf Glycoprotein Activates CD8+ T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma
A Mallick, S Barik, KK Goswami, S Banerjee, S Ghosh… - PLoS …, 2013 - journals.plos.org
In spite of sufficient data on Neem Leaf Glycoprotein (NLGP) as a prophylactic vaccine, little
knowledge currently exists to support the use of NLGP as a therapeutic vaccine. Treatment …
knowledge currently exists to support the use of NLGP as a therapeutic vaccine. Treatment …
Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancer
Myeloid-derived dendritic cells (DCs) generated from monocytes obtained from stage IIIB
cervical cancer (CaCx IIIB) patients show dysfunctional maturation; thus, antitumor T cell …
cervical cancer (CaCx IIIB) patients show dysfunctional maturation; thus, antitumor T cell …
A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth
A Das, S Barik, S Banerjee, A Bose… - Journal of …, 2014 - journals.lww.com
Carcinoembryonic antigen (CEA) is one of the promising tumor antigens mainly associated
with carcinoma of the colon, lung, breast, etc. and received wide attention for cancer …
with carcinoma of the colon, lung, breast, etc. and received wide attention for cancer …
[HTML][HTML] Neem leaf glycoprotein optimizes effector and regulatory functions within tumor microenvironment to intervene therapeutically the growth of B16 melanoma in …
Therapy with neem leaf glycoprotein (NLGP) inhibits murine B16-melanoma in vivo and
improves survivability. Studies on tumor-microenvironment (TME) from NLGP treated mice …
improves survivability. Studies on tumor-microenvironment (TME) from NLGP treated mice …
Induction of type 1 cytokines during neem leaf glycoprotein assisted carcinoembryonic antigen vaccination is associated with nitric oxide production
Involvement of the nitric oxide (NO) release in CEAMϕNLGP (carcinoembryonic antigen
pulsed macrophages with neem leaf glycoprotein) vaccination and its relationship with …
pulsed macrophages with neem leaf glycoprotein) vaccination and its relationship with …
Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNγ signaling
We have demonstrated augmentation of the CD3− CD56+ natural killer (NK) and CD8+
CD56− T-cell–mediated tumor cell cytotoxicity by neem leaf glycoprotein (NLGP). These NK …
CD56− T-cell–mediated tumor cell cytotoxicity by neem leaf glycoprotein (NLGP). These NK …